| Literature DB >> 31547851 |
Addis Darge1, Atsebaha Gebrekidan Kahsay2, Haftamu Hailekiros3, Selam Niguse3, Mahmud Abdulkader3.
Abstract
OBJECTIVE: To determine bacterial contaminants and their antimicrobial susceptibility patterns from medical equipment and inanimate surfaces.Entities:
Keywords: Antimicrobial susceptibility pattern; Bacterial contamination; Ethiopia; Inanimate surfaces; Medical equipment
Year: 2019 PMID: 31547851 PMCID: PMC6757422 DOI: 10.1186/s13104-019-4658-5
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Profile and distribution of isolated bacteria from medical equipment at Ayder Specialized Comprehensive Hospital October 2016 to June 2017
| Bacterial isolates | Stethoscope parts | Thermometers | Sphygmomanometer | Mattresses (n = 6) | Bedsides | Computers | CS table (n = 15) | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ear (n = 25) | Tubing (n = 17) | Diaphragm (n = 19) | TM (n = 6) | TS (n = 6) | SC (n = 10) | SB (n = 8) | BTT (n = 10) | BTB (n = 9) | CM (n = 7) | CE (n = 10) | CS (n = 9) | ||||
| Adult ICU | |||||||||||||||
| CoNS | 4 | 3 | 6 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 24 |
| | 7 | 4 | 3 | 0 | 0 | 2 | 1 | 2 | 2 | 1 | 0 | 2 | 1 | 2 | 27 |
| | 0 | 0 | 1 | 0 | 1 | 2 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6 |
| | 1 | 0 | 2 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 6 |
| Total | 12 | 7 | 12 | 1 | 1 | 4 | 3 | 3 | 4 | 4 | 2 | 4 | 2 | 4 | 63 |
| Pediatric ICU | |||||||||||||||
| CoNS | 1 | 1 | 0 | 0 | 0 | 3 | 1 | 2 | 1 | 2 | 0 | 0 | 2 | 2 | 15 |
| | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 1 | 2 | 0 | 0 | 10 |
| | 3 | 3 | 2 | 2 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 14 |
| | 1 | 1 | 1 | 0 | 0 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 |
| | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 2 |
| | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 2 |
| | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 0 | 5 |
| Total | 7 | 7 | 4 | 2 | 2 | 6 | 5 | 3 | 6 | 5 | 2 | 2 | 3 | 3 | 57 |
| Neonatal ICU | |||||||||||||||
| CoNS | 3 | 2 | 3 | 3 | 2 | NA | NA | NA | NA | NA | 2 | 2 | 1 | 3 | 21 |
| | 1 | 1 | 0 | 0 | 1 | NA | NA | NA | NA | NA | 1 | 0 | 2 | 3 | 9 |
| | 1 | 0 | 0 | 0 | 0 | NA | NA | NA | NA | NA | 0 | 0 | 0 | 0 | 1 |
| | 1 | 0 | 0 | 0 | 0 | NA | NA | NA | NA | NA | 0 | 1 | 1 | 2 | 5 |
| Total | 6 | 3 | 3 | 3 | 3 | NA | NA | NA | NA | NA | 3 | 3 | 4 | 8 | 36 |
BTB: bedside table bottom; BTT: bedside table top; CE: computer Enter key; CM: computer mouse; CoNs: Coagulase negative staphylococcus; CS table: computer standing table; CS: computer space bar; Diaphragm: stethoscope diaphragm; Ear: stethoscope ear piece; NA: none applicable; TM: thermometer mercury; TS: thermometer side; SB: sphygmomanometer bulb; SC: sphygmomanometer cuff; Tubing: stethoscope tubing
Antimicrobial susceptibility pattern of gram positives and negative from the medical inanimate surfaces at Ayder Specialized Comprehensive Hospital October 2016 to June 2017
| Isolates (N) | Pattern | E | P | AMC | CIP | CTR | TE | C | GEN | AMP | CX | Total (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CoNS (60) | S | 20 (33.3) | 24 (40) | 22 (37.2) | 46 (44) | 34 (57.6) | 52 (88.1) | 41 (72.8) | 50 (83) | 4 (6.7) | NA | 47.4 |
| I | 10 (16.7) | 1 (1.7) | 0 | 5 (8.4) | 14 (22) | 0 | 4 (6.7) | 4 (6.7) | 0 | NA | 6.7 | |
| R | 30 (50) | 35 (53.3) | 38 (62.7) | 9 (13.5) | 12 (20.3) | 8 (11.8) | 15 (23.7) | 6 (10.1) | 56 (93.2) | NA | 42.5 | |
| S | 8 (17.4) | 9 (19.5) | 17 (36.9) | 31 (67.4) | 19 (41.3) | 36 (78.2) | 31 (67.4) | 35 (76) | 5 (10.8) | 12 (26.1) | 40.5 | |
| I | 15 (32.6) | 3 (6.5) | 0 | 4 (8.6) | 14 (30.4) | 3 (6.5) | 3 (6.5) | 1 (2.1) | 0 | 0 | 8.8 | |
| R | 23 (50) | 34 (73.9) | 29 (63) | 11 (23.9) | 13 (28.2) | 7 (15.2) | 12 (26) | 10 (21.7) | 41 (89.1) | 34 (73.9) | 50.5 | |
| Total (106) | S | 28 (26.4) | 33 (31.1) | 39 (36.8) | 77 (72.6) | 53 (50) | 88 (83) | 75 (70.8) | 85 (80.2) | 9 (8.5) | 12 (26.1) | 44.9 |
| I | 25 (23.6) | 4 (3.8) | 0 | 9 (8.5) | 28 (26.4) | 3 (2.8) | 7 (6.6) | 5 (4.7) | 0 | 0 | 7.4 | |
| R | 53 (50) | 69 (65.1) | 67 (63.2) | 20 (18.9) | 25 (23.6) | 15 (14.2) | 26 (24.5) | 16 (15.1) | 97 (91.5) | 34 (73.9) | 47.9 |
AMC: amoxicillin–clavulanic; AMP: ampicillin; CX: cefoxitin; CRT: ceftriaxone; C: chloramphenicol; CIP: ciprofloxacin; CoNS: coagulase negative staphylococcus; E: erythromycin; GEN: gentamicin; I: intermediate; P: penicillin G; R: resistant; S: sensitive; TE: tetracycline
Multidrug resistant (MDR) pattern of isolated bacteria from medical equipments and inanimate surfaces at Ayder Specialized Comprehensive Hospital October 2016 to June 2017
| Bacterial species | Resisted antimicrobial agents | No. bacteria (%) for MDR | Bacterial species | Resisted antimicrobial agents | No. bacteria (%) for MDR | ||
|---|---|---|---|---|---|---|---|
| No. | Type | No. | Type | ||||
| Coagulase negative | R4 | E, AMC, CIP, AMP | 1 (1.7) |
| R3 | CIP, GEN, AMP | 1 (2.2) |
| R5 | E, P, AMC, C, AMP | 3 (5) | E, AMP, CX | 1 (2.2) | |||
| p, AMC, C, GEN, AMP | 2 (3.3) | R4 | E, P, AMP, CX | 4 (8.7) | |||
| p, AMC, CIP, TE, AMP | 2 (3.3) | AMC, C, AMP, CX | 1 (2.2) | ||||
| E, AMC, CIP, TE, AMP | 1 (1.7) | R5 | P, AMC, C, AMP, CX | 1 (2.2) | |||
| E, P, CIP, C, AMP | 1 (1.7) | E, P, AMC, AMP, CX | 3 (6.5) | ||||
| R6 | E, P, AMC, C, CTR, AMP | 2 (3.3) | P, AMC, CTR, AMP, CX | 1 (2.2) | |||
| E, P, AMC, CTR, GEN, AMP | 1 (1.7) | R6 | P, CIP, CTR, C, AMP, CX | 1 (2.2) | |||
| E, P, AMC, CTR, C, AMP | 1 (1.7) | E, P, AMC, CTR, AMP, CX | 1 (2.2) | ||||
| R7 | E, P, AMC, CTR, TE, C, AMP | 1 (1.7) | E, P, AMC, C, AMP, CX | 2 (4.3) | |||
| E, P, AMC, CIP, CTR, GEN, AMP | 1 (1.7) | E, AMC, C, GEN, AMP, CX | 1 (2.2) | ||||
| R9 | E, P, AMC, CIP, CTR, TE, C, GEN, AMP | 2 (3.3) | R7 | E, P, AMC, CTR, C, AMP, CX | 2 (4.3) | ||
| Total | 17 (28.3) | p, AMC, CIP, CTR, GEN, AMP, CX | 3 (6.5) | ||||
|
| R3 | CTR, CTX, AK | 1 (9.1) | E, P, CIP, CTR, C, AMP, CX | 1 (2.2) | ||
| R5 | AMC, CTR, AMP, CTX, NA | 2 (18.2) | E, P, AMC, TE, C, AMP, CX | 1 (2.2) | |||
| AMC, CTR, AMP, CTX, AK | 1 (9.1) | R8 | E, P, AMC, CIP, TE, GEN, AMP, CX | 1 (2.2) | |||
| AMC, CTR, C, AMP, CTX | 1 (9.1) | R9 | E, P, AMC, CIP, CTR, TE, GEN, AMP, CX | 2 (4.3) | |||
| R6 | AMC , CIP, CTR, C, CTX, NA | 1 (9.1) | R10 | E, P, AMC, CIP, CTR, TE, C, GEN, AMP, CX | 1 (2.2) | ||
| R7 | AMC, CTR, TE, C, AMP, CTX, NA | 1 (9.1) | Total | 27 (58.7) | |||
| R9 | AMC, CIP, CTR, TE, C, GEN, MP, CTX, NA | 1 (9.1) |
| R4 | AMC, AMP, NA, AK | 3 (20) | |
| Total | 8 (72.7) | Total | 3 (20) | ||||
P: penicillin; CX: cefoxitin; E: erythromycin; AMC: amoxicillin–clavulanic acid; AMP: ampicillin; CTR: ceftriaxone; CIP: ciprofloxacin; C: chloramphenicol; GEN: gentamicin; TE: tetracycline; AK: amikacin; CTX: cefotaxime; NA: nalidixic acid, R3; R4; R5; R6; R7; R8; R9; R10; R11; resistant to (3, 4, 5, 6, 7, 8, 9, 10, 11 antimicrobial agents), respectively, MDR; non-susceptible to ≥ 1 agent in ≥ 3 antimicrobial categories